Increase in CCR5 Δ32/Δ32 genotype in multiple sclerosis

作者: K. Pulkkinen , M. Luomala , H. Kuusisto , T. Lehtimaki , M. Saarela

DOI: 10.1046/J.1600-0404.2003.00233.X

关键词:

摘要: Chemokines and their receptors participate in the development of multiple sclerosis (MS) by guiding immune cells into brain tissue. A CCR5 Delta32 deletion mutation abolishes functional on cell surface may reduce entry lesion sites. To analyse significance this MS, we compared frequencies genotype peripheral blood mononuclear from 89 MS patients 119 healthy controls. The was further with RNA protein expression 48 In all patients, Delta32/32 found 6.7% frequency, whereas it present only 0.8% controls (6/89 vs 1/119, P = 0.01). Specifically, Delta32/Delta32 increased (11.5%, 0.05) among primary progressive 4.8% other subtypes amount CD4(+) analysed (nine 18 secondary 21 relapsing-remitting MS) 13 decreased genotype, being 8.9% wt/wt, 7.7% wt/Delta32 4.3% Delta32/Delta32. these significantly as that wt/wt individuals (P 0.004). number our suggests could contribute a general risk factor for MS. However, neither levels or correlated subtype, neurological disability expressed expanded status scale, disease progression index. Our results suggest lack does not protect but rather predispose to chronic course disease. This would imply view redundancy chemokine system, ligands must be assumed function through closely related receptors.

参考文章(40)
Albert Zlotnik, Osamu Yoshie, Chemokines: A New Classification System and Their Role in Immunity Immunity. ,vol. 12, pp. 121- 127 ,(2000) , 10.1016/S1074-7613(00)80165-X
TOMI PASTINEN, KIRSI LIITSOLA, PAAVO NIINI, MIKA SALMINEN, ANN-CHRISTINE SYVÄNEN, Contribution of the CCR5 and MBL genes to susceptibility to HIV type 1 infection in the Finnish population. AIDS Research and Human Retroviruses. ,vol. 14, pp. 695- 698 ,(1998) , 10.1089/AID.1998.14.695
Craig Gerard, Barrett J. Rollins, Chemokines and disease Nature Immunology. ,vol. 2, pp. 108- 115 ,(2001) , 10.1038/84209
David M. Markovitz, Robert M. Strieter, Nina L. Woodford, Michael J. Coffey, Brian R. Lane, Rosemary Rochford, TNF-α Inhibits HIV-1 Replication in Peripheral Blood Monocytes and Alveolar Macrophages by Inducing the Production of RANTES and Decreasing C-C Chemokine Receptor 5 (CCR5) Expression Journal of Immunology. ,vol. 163, pp. 3653- 3661 ,(1999)
I Zapico, E Coto, A Rodríguez, C Alvarez, JC Torre, V Alvarez, CCR5 (chemokine receptor-5) DNA-polymorphism influences the severity of rheumatoid arthritis. Genes and Immunity. ,vol. 1, pp. 288- 289 ,(2000) , 10.1038/SJ.GENE.6363673
Jianglin He, Youzhi Chen, Michael Farzan, Hyeryun Choe, Asa Ohagen, Suzanne Gartner, Jorge Busciglio, Xiaoyu Yang, Wolfgang Hofmann, Walter Newman, Charles R Mackay, Joseph Sodroski, Dana Gabuzda, None, CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia Nature. ,vol. 385, pp. 645- 649 ,(1997) , 10.1038/385645A0
Monsef Benkirane, Dong-Yan Jin, Rene F. Chun, Richard A. Koup, Kuan-Teh Jeang, Mechanism of Transdominant Inhibition of CCR5-mediated HIV-1 Infection by ccr5Δ32 Journal of Biological Chemistry. ,vol. 272, pp. 30603- 30606 ,(1997) , 10.1074/JBC.272.49.30603
Pentti J Tienari, Satu Kuokkanen, Tomi Pastinen, Juhani Wikström, Antti Sajantila, Magnhild Sandberg-Wollheim, Jorma Palo, Leena Peltonen, Golli-MBP gene in multiple sclerosis susceptibility Journal of Neuroimmunology. ,vol. 81, pp. 158- 167 ,(1998) , 10.1016/S0165-5728(97)00171-9
Yaoxing Huang, William A. Paxton, Steven M. Wolinsky, Avidan U. Neumann, Linqi Zhang, Tian He, Stanley Kang, Daniel Ceradini, Zhanqun Jin, Karina Yazdanbakhsh, Kevin Kunstman, Daniel Erickson, Elizabeth Dragon, Nathaniel R. Landau, John Phair, David D. Ho, Richard A. Koup, The role of a mutant CCR5 allele in HIV–1 transmission and disease progression Nature Medicine. ,vol. 2, pp. 1240- 1243 ,(1996) , 10.1038/NM1196-1240